Krystal Biotech, Inc.KRYSNASDAQ
LOADING
|||
Analyst Sentiment
Analysts lean bullish — 100% recommend buying.
Consensus Rating
Buy
16 analysts·Moderate coverage
100%
Rating Distribution
Strong Buy
00%
Buy
16100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Current price is 5% above analyst consensus — near fair value expected.
Bear Case
$216.00
-23%
Consensus
$269.25
-5%
Bull Case
$327.00
+16%
Price Range16 analysts
Low
Consensus
High
$216.00
$327.00
Current Target
Current Price
$282.27
Above Target
$13.02
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
2026E$7.72(7 analysts)
P/E41x
Current: 41.1xActual
Estimate
Range (Low–High)
Forward Growth Estimates (YoY)
FY2027
Rev+29.61%
EPS+33.22%
FY2028
Rev+25.08%
EPS+24.54%
FY2029
Rev+23.96%
EPS+45.42%
Earnings Surprises
Beat rate:67%(8/12 quarters)
Avg surprise:+13.4%
Beat
Miss
Inline
Estimate